Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis

Saved in:
Bibliographic Details
Published in:The Oncologist
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552802044739584
collection WordPress RSS
FRELIP Feed Integration
container_title The Oncologist
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:61417
institution FRELIP
journal_source_facet The Oncologist
last_indexed 2026-06-20T21:26:42.861Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis
title_alt Prevalencia de eventos adversos tras terapias de redirección de células T en pacientes con cáncer de próstata metastásico resistente a la castración: un análisis agrupado
Prévalence des événements indésirables après les thérapies de redirection des lymphocytes T chez les patients atteints de cancer de la prostate métastatique résistant à la castration : une analyse poolée
Prevalência de eventos adversos após terapias de redirecionamento de células T em pacientes com câncer de próstata metastático resistente à castração: uma análise agrupada
title_auth Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis
title_es_txt Prevalencia de eventos adversos tras terapias de redirección de células T en pacientes con cáncer de próstata metastásico resistente a la castración: un análisis agrupado
title_fr_txt Prévalence des événements indésirables après les thérapies de redirection des lymphocytes T chez les patients atteints de cancer de la prostate métastatique résistant à la castration : une analyse poolée
title_full Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis
title_fullStr Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis
title_full_unstemmed Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis
title_pt_txt Prevalência de eventos adversos após terapias de redirecionamento de células T em pacientes com câncer de próstata metastático resistente à castração: uma análise agrupada
title_short Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis
title_sort prevalence of adverse events following t-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis
topic Oncology
General
Oncology
url https://academic.oup.com/oncolo/article/doi/10.1093/oncolo/oyag172/8666983?rss=1